The pharmacists fighting high drug prices

We live in an age of global mass tourism. Last year, the UN estimated 1.5 billion people travelled to another country. While many places depend on tourism for income and employment, it can come at a significant environmental and social cost.We take a tour of Dubrovnik in Croatia, ...  Show more

How much work do you do to keep your household running smoothly? Figures suggest domestic work still falls mostly to women - leading to resentment and burnout. This week we’re hearing from Indonesia and Croatia about projects helping change that. In rural Indonesia we visit the i ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

High prescription costs are a major barrier to the optimal treatment of many health conditions. Prescribers need tools to help patients find the lowest drug costs. Author Hussain S. Lalani, MD, MPH, MSc, of Brigham and Women's Hospital and Harvard Medical School joins JAMA Sen ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...

Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How ...  Show more